NVE Corporation reported fiscal Q4 results after the close on May 6, delivering the clearest catalyst of a strong week. EPS came in at $1.02, up from $0.80 a year ago. Revenue hit $7.65 million, ahead of the prior-year $7.27 million. The company simultaneously declared a quarterly cash dividend. The stock had already moved hard into the print — up 7.4% on the week and 22.7% over the past month to close at $84.98 — making this an earnings-confirmed rally rather than a speculative one.
Short sellers have been reducing their exposure into the strength, though they haven't abandoned the trade. Short interest dropped from a recent peak of around 322,000 shares in mid-April to roughly 294,000 today — a decline of about 8.5% from that high. As a percentage of the free float, the position now reads at approximately 6.1%, still meaningful for a micro-cap spintronics name. The pace of reduction has been gradual rather than a sudden short-side panic. The ORTEX short score, at 47.3 and ticking up from 46.5 at the start of the week, reflects a position that is moderating but not capitulating.
The borrow market tells a relaxed story. Cost to borrow has edged up 27% on the week but remains exceptionally cheap at just 0.47% annualised — a level that imposes no real pain on a short position. Availability in the lending pool is ample: with utilisation around 6% against a 52-week peak of 22.8%, there is no squeeze pressure visible. Shorts can stay, add, or cover with minimal friction. That combination of modest short interest, low cost, and high availability argues against any near-term mechanically-driven covering.
The peer group had a strong week across the board. MRAM was the standout, surging 49.5% on the week — an outlier that likely reflects stock-specific news rather than sector momentum. NVTS added 16.1% and PDFS gained 15.6%. NVEC's 7.4% weekly gain looks restrained by comparison, though that context cuts both ways: NVEC moved first and with more consistency over the month, while peers may be playing catch-up to a broader small-cap semiconductor re-rating.
On the institutional side, the ownership structure is concentrated. Defiance ETFs and Penserra Capital Management each hold approximately 11.4% of shares — passive and semi-passive vehicles whose flows track index demand rather than fundamental conviction. Vanguard and BlackRock together account for a further 16%. Renaissance Technologies held 3.7% as of December, a name worth noting given its quantitative nature. The tight institutional base means trading in NVEC remains thin and event-driven; a strong earnings print like today's can move the stock substantially on modest volume.
The prior two earnings releases support that observation. NVEC gained 4.7% the day after January's Q3 release, and 11.2% the day after the Q2 print in October — the latter followed by a further 5.3% over the subsequent five days. With fiscal Q4 results now out and a quarterly dividend reaffirmed, the immediate catalyst has cleared. What matters next is whether the EPS momentum — now visibly accelerating — draws fresh institutional attention to a name that has historically traded in a narrow band and rewarded patient holders.
See the live data behind this article on ORTEX.
Open NVEC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
